Gene/Proteome Database (LMPD)
LMPD ID
LMP000405
Gene ID
Species
Homo sapiens (Human)
Gene Name
apolipoprotein C-II
Gene Symbol
Synonyms
APO-CII; APOC-II
Alternate Names
apolipoprotein C-II; apolipoprotein C2
Chromosome
19
Map Location
19q13.2
Summary
This gene encodes a lipid-binding protein belonging to the apolipoprotein gene family. The protein is secreted in plasma where it is a component of very low density lipoprotein. This protein activates the enzyme lipoprotein lipase, which hydrolyzes triglycerides and thus provides free fatty acids for cells. Mutations in this gene cause hyperlipoproteinemia type IB, characterized by hypertriglyceridemia, xanthomas, and increased risk of pancreatitis and early atherosclerosis. This gene is present in a cluster with other related apolipoprotein genes on chromosome 19. Naturally occurring read-through transcription exists between this gene and the neighboring upstream apolipoprotein C-IV (APOC4) gene. [provided by RefSeq, Mar 2011]
Orthologs
Proteins
apolipoprotein C-II precursor | |
---|---|
Refseq ID | NP_000474 |
Protein GI | 32130518 |
UniProt ID | P02655 |
mRNA ID | NM_000483 |
Length | 101 |
RefSeq Status | REVIEWED |
MGTRLLPALFLVLLVLGFEVQGTQQPQQDEMPSPTFLTQVKESLSSYWESAKTAAQNLYEKTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE | |
sig_peptide: 1..22 experiment: experimental evidence, no additional details recorded note: propagated from UniProtKB/Swiss-Prot (P02655.1) calculated_mol_wt: 2387 peptide sequence: MGTRLLPALFLVLLVLGFEVQG mat_peptide: 23..101 product: Apolipoprotein C-II experiment: experimental evidence, no additional details recorded note: propagated from UniProtKB/Swiss-Prot (P02655.1) calculated_mol_wt: 8915 peptide sequence: TQQPQQDEMPSPTFLTQVKESLSSYWESAKTAAQNLYEKTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE |
Gene Information
Gene Ontology (GO Annotations)
GO ID | Source | Type | Description |
---|---|---|---|
GO:0042627 | IDA:BHF-UCL | C | chylomicron |
GO:0005769 | TAS:Reactome | C | early endosome |
GO:0005576 | NAS:UniProtKB | C | extracellular region |
GO:0005615 | IDA:BHF-UCL | C | extracellular space |
GO:0070062 | IDA:UniProt | C | extracellular vesicular exosome |
GO:0034363 | IDA:BHF-UCL | C | intermediate-density lipoprotein particle |
GO:0034362 | IDA:BHF-UCL | C | low-density lipoprotein particle |
GO:0034366 | IDA:BHF-UCL | C | spherical high-density lipoprotein particle |
GO:0034361 | IDA:BHF-UCL | C | very-low-density lipoprotein particle |
GO:0055102 | IDA:BHF-UCL | F | lipase inhibitor activity |
GO:0008289 | IDA:BHF-UCL | F | lipid binding |
GO:0060230 | IDA:BHF-UCL | F | lipoprotein lipase activator activity |
GO:0016004 | IDA:BHF-UCL | F | phospholipase activator activity |
GO:0043274 | IPI:BHF-UCL | F | phospholipase binding |
GO:0042803 | IMP:BHF-UCL | F | protein homodimerization activity |
GO:0033344 | IDA:BHF-UCL | P | cholesterol efflux |
GO:0042632 | IC:BHF-UCL | P | cholesterol homeostasis |
GO:0034382 | IDA:BHF-UCL | P | chylomicron remnant clearance |
GO:0034371 | IC:BHF-UCL | P | chylomicron remodeling |
GO:0034384 | IMP:BHF-UCL | P | high-density lipoprotein particle clearance |
GO:0016042 | IEA:UniProtKB-KW | P | lipid catabolic process |
GO:0042157 | TAS:Reactome | P | lipoprotein metabolic process |
GO:0043086 | IDA:GOC | P | negative regulation of catalytic activity |
GO:0032375 | IMP:BHF-UCL | P | negative regulation of cholesterol transport |
GO:0045833 | IDA:BHF-UCL | P | negative regulation of lipid metabolic process |
GO:0048261 | IDA:BHF-UCL | P | negative regulation of receptor-mediated endocytosis |
GO:0010916 | IDA:BHF-UCL | P | negative regulation of very-low-density lipoprotein particle clearance |
GO:0033700 | IDA:BHF-UCL | P | phospholipid efflux |
GO:0007603 | TAS:Reactome | P | phototransduction, visible light |
GO:0045723 | IDA:BHF-UCL | P | positive regulation of fatty acid biosynthetic process |
GO:0051006 | IDA:BHF-UCL | P | positive regulation of lipoprotein lipase activity |
GO:0010518 | IDA:BHF-UCL | P | positive regulation of phospholipase activity |
GO:0060697 | IDA:BHF-UCL | P | positive regulation of phospholipid catabolic process |
GO:0010898 | IDA:BHF-UCL | P | positive regulation of triglyceride catabolic process |
GO:0010902 | IC:BHF-UCL | P | positive regulation of very-low-density lipoprotein particle remodeling |
GO:0001523 | TAS:Reactome | P | retinoid metabolic process |
GO:0043691 | IC:BHF-UCL | P | reverse cholesterol transport |
GO:0044281 | TAS:Reactome | P | small molecule metabolic process |
GO:0070328 | IMP:BHF-UCL | P | triglyceride homeostasis |
GO:0034370 | TAS:BHF-UCL | P | triglyceride-rich lipoprotein particle remodeling |
GO:0034372 | TAS:BHF-UCL | P | very-low-density lipoprotein particle remodeling |
REACTOME Pathway Links
REACTOME Pathway ID | Description |
---|---|
REACT_6841 | Chylomicron-mediated lipid transport |
REACT_13621 | HDL-mediated lipid transport |
REACT_24968 | Retinoid metabolism and transport |
Domain Information
UniProt Annotations
Entry Information
Comments
Comment Type | Description |
---|---|
Disease | Hyperlipoproteinemia 1B (HLPP1B) [MIM |
Function | Component of chylomicrons, very low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL) in plasma. Plays an important role in lipoprotein metabolism as an activator of lipoprotein lipase. Both proapolipoprotein C-II and apolipoprotein C-II can activate lipoprotein lipase. In normolipidemic individuals, it is mainly distributed in the HDL, whereas in hypertriglyceridemic individuals, predominantly found in the VLDL and LDL. |
Ptm | Proapolipoprotein C-II is synthesized as a sialic acid containing glycoprotein which is subsequently desialylated prior to its proteolytic processing. |
Ptm | Proapolipoprotein C-II, the major form found in plasma undergoes proteolytic cleavage of its N-terminal hexapeptide to generate apolipoprotein C-II, which occurs as the minor form in plasma. |
Similarity | Belongs to the apolipoprotein C2 family. |
Subcellular Location | Secreted . |
Tissue Specificity | Liver and intestine. |
Identical and Related Proteins
Unique RefSeq proteins for LMP000405 (as displayed in Record Overview)
Protein GI | Database | Accession | Length | Protein Name |
---|---|---|---|---|
32130518 | RefSeq | NP_000474 | 101 | apolipoprotein C-II precursor |
Identical Sequences to LMP000405 proteins
Reference | Database | Accession | Length | Protein Name |
---|---|---|---|---|
GI:32130518 | GenBank | EAW57313.1 | 101 | apolipoprotein C-II, isoform CRA_a [Homo sapiens] |
GI:32130518 | GenBank | ACM81716.1 | 101 | Sequence 7214 from patent US 6812339 |
GI:32130518 | GenBank | ACN81313.1 | 101 | apolipoprotein C-II [Homo sapiens] |
GI:32130518 | GenBank | AEK13840.1 | 101 | Sequence 9 from patent US 7972802 |
GI:32130518 | GenBank | AGM56993.1 | 101 | Sequence 9 from patent US 8420337 |
GI:32130518 | GenBank | AHE01110.1 | 101 | Sequence 56026 from patent US 8586006 |
Related Sequences to LMP000405 proteins
Reference | Database | Accession | Length | Protein Name |
---|---|---|---|---|
GI:32130518 | GenBank | AAP35354.1 | 101 | apolipoprotein C-II [Homo sapiens] |
GI:32130518 | GenBank | AAH05348.3 | 101 | Apolipoprotein C-II [Homo sapiens] |
GI:32130518 | GenBank | ACE87064.1 | 101 | apolipoprotein C-II protein, partial [synthetic construct] |
GI:32130518 | GenBank | ACE87745.1 | 101 | apolipoprotein C-II protein [synthetic construct] |
GI:32130518 | GenBank | AGB62518.1 | 236 | Sequence 79 from patent US 8288091 |
GI:32130518 | GenBank | AGB62524.1 | 123 | Sequence 85 from patent US 8288091 |